Gaurav Sharma, MD
Vascular Surgery · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sharma’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$3,531
Medicare paid this office $3,531 for 12 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Leg revascularization (restoring blood flow) | 1-10 | None |
Who their Medicare patients are
12 Original Medicare patients in 2024. Average age 65 · 85 and older 0% · Health risk score 5.81. Sicker patients than 9 in 10 peers; the typical vascular surgery clinician is at 2.33.
The office billed $14,996, Medicare allowed $4,643 and paid $3,531; for 27 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
$10,358
Pharmacies billed $10,358 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 42% of their Part D prescriptions (34 of 82) in 2024. A higher opioid share than 9 in 10 peers; the typical vascular surgery clinician is at 11%.
69 generic and 13 brand-name prescriptions · $10,358 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 11 | $9,159 | $833 |
| Clopidogrel | 20 | $300 | $15 |
| Cilostazol | 12 | $205 | $17 |
| Oxycodone | 31 | $193 | $6 |
Year by year
| 2024 | 82 | 40 | 42% (34) | 16% | $10,358 |
| 2023 | 66 | 35 | 53% (35) | None | $5,964 |
| 2022 | 49 | 32 | 51% (25) | None | $2,106 |
| 2021 | 53 | 36 | 49% (26) | None | $2,794 |
| 2020 | 32 | 13 | None | None | $711 |
| 2019 | 23 | 12 | None | 0% | $153 |
| 2018 | 26 | 18 | 62% (16) | 0% | $2,497 |
| 2016 | 11 | None | None | 0% | $58 |
| 2013 | 28 | 21 | 71% (20) | None | $556 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Clopidogrel | 18 | $325 | $18 |
| Oxycodone | 34 | $248 | $7 |
2022: 1 drug
| Oxycodone | 24 | $157 | $7 |
2021: 2 drugs
| Clopidogrel | 15 | $275 | $18 |
| Oxycodone | 25 | $158 | $6 |
2020: 1 drug
| Clopidogrel | 24 | $219 | $9 |
2019: 1 drug
| Clopidogrel | 21 | $147 | $7 |
2018: 1 drug
| Oxycodone | 15 | $57 | $4 |
2013: 1 drug
| Oxycodone | 12 | $113 | $9 |
Money from drug and device companies
$24 in 2024
| 2024 | 1 | 1 | None | $24 |
| 2022 | 1 | 1 | None | $79 |
| 2021 | 1 | 1 | None | $14 |
| 2020 | 2 | 7 | None | $217 |
| 2019 | 2 | 6 | None | $264 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Globus Medical | Corridor | $24 | 1 payment
|
See the published payment
| Globus Medical | Meals · 2024-03-23 | Corridor | $24 |
See earlier years (2022, 2021, 2020, 2019)
2022: $79
| Chiesi USA | Kengreal | $79 | 1 payment
|
2021: $14
| AstraZeneca Pharmaceuticals LP | Brilinta | $14 | 1 payment
|
2020: $217
| Endologix | None | $140 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $77 | 4 payments
|
2019: $264
| Medtronic Vascular | None | $191 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $73 | 5 payments
|
Professional record
- NPI
- 1003115726
- Trained
- University of Southern California Keck School of Medicine, 2011
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2086S0129X (2086S0129X); Student in a training program (390200000X)
- Mailing address
- 710 Lawrence Expy Dept 290, Santa Clara, CA, 95051
- NPI first listed
- 2011-03-21
- NPI last updated
- 2025-01-29
- NPI record certified
- 2025-01-29
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.